Greenwich LifeSciences (GLSI) Assets Average (2020 - 2025)

Greenwich LifeSciences' Assets Average history runs 6 years deep, the most recent figure standing at $5.0 million for Q4 2025.

• Quarterly Assets Average rose 0.67% year-over-year to $5.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 million (up 0.67% YoY) and the FY2025 annual result came in at $5.1 million, down 7.37% from the prior year.
• Assets Average was $5.0 million for Q4 2025 at Greenwich LifeSciences, up from $3.5 million in the prior quarter.
• Across five years, Assets Average topped out at $30.1 million in Q2 2021 and bottomed at $2.9 million in Q2 2025.
• A 5-year average of $13.6 million and a median of $10.7 million in 2023 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2021 — Assets Average jumped 60.62% — and 2025, when it plunged 53.87%.
• Greenwich LifeSciences' Assets Average stood at $28.1 million in 2021, then slumped by 48.12% to $14.6 million in 2022, then plunged by 44.57% to $8.1 million in 2023, then slumped by 38.56% to $5.0 million in 2024, then rose by 0.67% to $5.0 million in 2025.
• Business Quant data shows GLSI's Assets Average at $5.0 million in Q4 2025, $3.5 million in Q3 2025, and $2.9 million in Q2 2025.